Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Ritalin

PreclinicalSmall molecule

Ritalin is one of 92 small molecule programs targeting Cognition. It is currently in Preclinical.

2

Indications

16

Total Trials

0

Active Trials

91

Competitors

Pipeline

Status by Indication[3][1]

Indication

CognitionActive, not recruiting

ChildrenCompleted

CognitionPreclinical

Active, not recruiting

ChildrenPreclinical

Completed

Competition

Competitive Landscape

85 competitors in Cognition

#DrugCompanyPhaseTrials

Pitocin

Xarelto

Neurontin

VViatris Specialty LLC

Ambien

PPurdue Pharma LP

Osmitrol

BB. Braun Medical Inc.

Zanaflex

LLegacy Health System

Namenda

Nuplazid

AACADIA Pharmaceuticals Inc.

Remimazolam Tosilate

FFujian Shengdi Pharmaceutical Co., Ltd.

Psilocybin

COMPASS Pathways

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Attention Deficit Hyperactivity Disorder5 trials

A Comparative Effectiveness Study Evaluating OROS Methylphenidate HCl, Ritalin (Methylphenidate HCl), and Placebo for the Treatment of Attention Deficit Hyperactivity Disorder in Children

Completed·AAlza Corporation, DE, USA·Phase 3·NCT00269789

Influence of Stimulant Medication on Brain Processes for Decision Making in Attention Deficit Hyperactivity Disorder

Completed·MMats Fredriksen·Phase 4·NCT01831622·131 enrolled

A Multicenter Study Comparing the Efficacy and Safety of OROS Methylphenidate HCl, Ritalin (Methylphenidate HCl) and Placebo in Children With Attention Deficit Hyperactivity Disorder

Completed·AAlza Corporation, DE, USA·Phase 3·NCT00269802

Show 2 more trials

Amantadine Versus Ritalin in the Treatment of Attention Deficit Hyperactivity Disorder (ADHD)

Unknown status·TTehran University of Medical Sciences·Phase 2·NCT01099059·40 enrolled

An Effectiveness and Safety Study Evaluating OROS Methylphenidate Hydrochloride (HCl), Ritalin (Methylphenidate HCl) and Placebo in Children With Attention Deficit Hyperactivity Disorder

Completed·AAlza Corporation, DE, USA·Phase 3·NCT00269776

Rehabilitation2 trials

Cognitive-Motor Rehabilitation, Stimulant Drugs, and Active Control in the Treatment of ADHD

Completed·—·N/A·NCT02780102·48 enrolled

Computer-assisted Cognitive Rehabilitation (CACR), Placebo CACR and Psycho-stimulants in the Treatment of ADHD

Completed·—·Phase 3·NCT01675804·34 enrolled

Children1 trial

Effects of Ritalin on Postural Stability of Hyper Active Children

Completed·SSoroka University Medical Center·N/A·NCT00485797·30 enrolled

Attention1 trial

Clinical and Pharmacogenetic Study of Attention Deficit With Hyperactivity Disorder (ADHD)

Completed·MMcGill University·Phase 4·NCT00483106·885 enrolled

Elderly1 trial

A Study To Evaluate The Difference In iPad-Based Cognitive Video Game (Akili Interactive's Project: EVO) Performance In Amyloid-Positive Versus Amyloid-Negative Healthy Elderly Volunteers

Completed· Pfizer logo

Pfizer··NCT02265718·97 enrolled

6 more indications

Treatment1 trial

Identifying Characteristic Signature of Attention Deficit / Hyperactivity Disorder (ADHD) and Ritalin Treatment

Unknown status·HHadassah Medical Organization·N/A·NCT01962181·40 enrolled

Function1 trial

Dopamine and Muscle Function in the Heat

Unknown status·—·N/A·NCT03515668·6 enrolled

Prostate Cancer1 trial

Psychostimulants for Fatigue in Prostate Cancer

Completed·MMemorial Sloan Kettering Cancer Center·Phase 2·NCT00138138·120 enrolled

Cognition1 trial

OT and Social Cognition in Children With ADHD: Impact of MPH

Completed·SShalvata Mental Health Center·N/A·NCT03788902·90 enrolled

Multiple Sclerosis1 trial

Evaluation of Efficiency of Ritalin in Multiple Sclerosis (MS) Patients

Unknown status·SSheba Medical Center·Phase 1·NCT00220493·80 enrolled

Unspecified1 trial

Motivation and Methylphenidate

Completed·IInstitut National de la Santé Et de la Recherche Médicale, France·Phase 1·NCT03190681·35 enrolled

Sources

References

[1]
ClinicalTrials.gov — 16 trial records for Ritalin. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Ritalin compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Ritalin. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Pfizer company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: Pfizer

Related News